Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | TSHR | P16473 | 4/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.65 |
| ▸ | APP | P05067 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 6/20 | 0.55 |
| ▸ | RAB9A | P51151 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | NSD2 | O96028 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.53 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.53 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17278995 | 1.00 | ALDH1A1 (0.65) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217836 | 0.88 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL1405467 | 0.88 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217840 | 0.88 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL3217829 | 0.88 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL1405466 | 0.88 | ALDH1A1 (0.81) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL671950 | 0.85 | APP (0.73) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL11341921 | 0.81 | ALDH1A1 (0.71) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL11341925 | 0.81 | ALDH1A1 (0.71) | ALDH1A1TSHRMAPK1HSD17B10TDP1 | |
| SCHEMBL17278970 | 0.81 | ALDH1A1 (0.71) | ALDH1A1TSHRMAPK1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240383170-A1 | FLEXIBLE AND SMART WOOD WITH RESPONSIVE FUNCTION, PREPARATION METHOD THEREOF AND ACTUATOR | NANJING FORESTRY UNIVERSITY (CN) | 2024-11-21 | — | — | US | claimed |
| US-20240383170-A1 | FLEXIBLE AND SMART WOOD WITH RESPONSIVE FUNCTION, PREPARATION METHOD THEREOF AND ACTUATOR | NANJING FORESTRY UNIVERSITY (CN) | 2024-11-21 | — | — | US | disclosed |
| CN-108273478-B | Formaldehyde removal composition and product | 李怀玉 | 2021-03-02 | — | — | CN | disclosed |
| US-20100150833-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC | 2010-06-17 | — | — | US | disclosed |
| US-20100150833-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC | 2010-06-17 | — | — | US | disclosed |
| US-20100143253-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC | 2010-06-10 | — | — | US | disclosed |
| US-20100143251-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC | 2010-06-10 | — | — | US | disclosed |
| US-20100143253-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC | 2010-06-10 | — | — | US | disclosed |
| US-20100143251-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC | 2010-06-10 | — | — | US | disclosed |
| US-7700616-B2 | Compounds and amyloid probes thereof for therapeutic and imaging uses | MOLECULAR NEUROIMAGING, LLC. (US) | 2010-04-20 | — | — | US | disclosed |
| US-7700616-B2 | Compounds and amyloid probes thereof for therapeutic and imaging uses | MOLECULAR NEUROIMAGING, LLC. (US) | 2010-04-20 | — | — | US | disclosed |
| WO-2008118122-A2 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20070258887-A1 | Compounds and amyloid probes thereof for therapeutic and imaging uses | MOLECULAR NEUROIMAGING, LLC. | 2007-11-08 | — | — | US | disclosed |
| US-20070258887-A1 | Compounds and amyloid probes thereof for therapeutic and imaging uses | MOLECULAR NEUROIMAGING, LLC. | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258887-A1 | Compounds and amyloid probes thereof for therapeutic and imaging uses | APP, BACE1, BACE2 | ALDH1A1 1882/4885TSHR 4072/4885MAPK1 3702/4885 |
| US-20100143253-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | APP, BACE1, BACE2 | ALDH1A1 1882/4885TSHR 4072/4885MAPK1 3702/4885 |
| US-20100150833-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | APP, BACE1, BACE2 | ALDH1A1 1882/4885TSHR 4072/4885MAPK1 3702/4885 |
| US-20100143251-A1 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | APP, BACE1, BACE2 | ALDH1A1 1882/4885TSHR 4072/4885MAPK1 3702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.